This article will review the progress of immune therapy in renal carcinoma.
现综述肾癌尤其是晚期肾癌在免疫治疗方面的进展。
Conclusion Distant metastasis is the main cause of death for renal carcinoma after surgery.
结论远地转移是肾癌术后主要致死原因。
Renal cell carcinoma (RCC) is the most common cancer of kidney in China.
肾细胞癌是我国泌尿生殖系统最常见的肿瘤之一。
Objective: To study the diagnosis and treatment of renal cell carcinoma.
目的：探讨肾细胞癌的诊断及手术治疗。
Objective: To discuss the treatment for incidental renal cell carcinoma.
目的：探讨偶发性肾细胞癌的治疗方法。
Tissue, Section, Human Tumor, Kidney Tumor, Renal Cell Carcinoma (Paraffin).
组织，切片，人肿瘤，肾肿瘤，肾癌(石蜡切片)。
Conclusion: Chemotherapy with single drug is not a good treatment for renal cell carcinoma.
结论：单一药物的化疗不是肾脏肿瘤治疗的理想方案。
Conclusion: Chemotherapy with single drug is not a good treatment for renal cell carcinoma.
结论：单一药物的化疗不是肾脏肿瘤治疗的理想方案。
应用推荐